An Active Surveillance Study to Monitor the Real-World Long-term Safety of Somatrogon Among Paediatric Patients in Europe

First published 28/11/2023

Last updated 21/07/2025

EU PAS number:

EUPAS107217

Study

Planned

Download as PDF

Documents

Study protocol

Initial protocol

C0311023_SOMATROGON PROTOCOL FINAL_05AUG2022.pdf

English (744.81 KB - PDF)View document

Updated protocol

C0311023_SOMATROGON PROTOCOL AMENDMENT 1 _20MAR2023

First published: 16/07/2025

English (472.55 KB - PDF)View document

C0311023_SOMATROGON_PROTOCOL_AMENDMENT_CLEAN_20MAR2023.pdf

First published: 15/04/2025

English (472.55 KB - PDF)View document

Study results

Study report

Other information